Design and activity of 2nd generation, dual-targeted CAR T cell factories against ccRCC

Full Text @ Edgewood Coll

Beyond conventional immune-checkpoint inhibition—novel immunotherapies for renal cell carcinoma

DA Braun, Z Bakouny, L Hirsch, R Flippot… - Nature reviews Clinical …, 2021 - nature.com
The management of advanced-stage renal cell carcinoma (RCC) has been transformed by
the development of immune-checkpoint inhibitors (ICIs). Nonetheless, most patients do not …
被引用次数：258 相关文章 所有 4 个版本
[PDF] springer.comFull Text @ Edgewood Coll

Evolution of cell therapy for renal cell carcinoma

Y Wang, ER Suarez, G Kastrunes, NSP de Campos… - Molecular Cancer, 2024 - Springer
Abstract Treatment for renal cell carcinoma (RCC) has improved dramatically over the last
decade, shifting from high-dose cytokine therapy in combination with surgical resection of …
被引用次数：23 相关文章 所有 11 个版本
[HTML] nih.govFull Text @ Edgewood Coll

[HTML][HTML] Beyond conventional immune checkpoint inhibition: renal cell carcinoma at the forefront of solid tumor immunology

DA Braun, Z Bakouny, L Hirsch, R Flippot… - Nature reviews …, 2021 - ncbi.nlm.nih.gov
The management of advanced renal cell carcinoma (RCC) has been transformed by the
development of immune checkpoint inhibitors (ICIs), but still most RCC patients do not …
被引用次数：3 相关文章